ADC Therapeutics SA Annual Nonoperating Income (Expense) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ADC Therapeutics SA quarterly/annual Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
  • ADC Therapeutics SA Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.06M, a 12.9% increase year-over-year.
  • ADC Therapeutics SA Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$26.8M.
  • ADC Therapeutics SA annual Nonoperating Income (Expense) for 2023 was -$29.4M, a 25.4% decline from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$29.4M -$5.96M -25.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$23.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.